Mathew
Shearman

Mathew Shearman advises clients on shaping their business environment through integrated, cross-functional strategic communications. He serves as the co-chair of the Global Health Practice. With APCO since 2022, Mathew brings unique experience working at the intersection of health care public affairs and crisis, policy, market access and corporate reputation disciplines to advise clients on enhancing their corporate reputation, protecting their license to operate and communicating the value of innovation.

Our work empowers the world’s most innovative organizations to improve health and advance health equity.

Mathew counsels executives from leading health care companies to navigate the geopolitical, issues-driven and health care trends that are rapidly disrupting their operating environment. Drawing on experience from the US, UK and EU markets, he guides APCO’s global health practice in empowering clients to promote health and advance health care equity.

Mathew joined APCO from Burson (formally Burson-Marsteller, BCW Global) where he provided strategic counsel to numerous Fortune 500 companies. He has counseled clients to successfully navigate reputational risks during litigation, product recalls, counterfeiting, clinical data readouts and cybersecurity challenges. With deep experience developing both disease awareness and policy-focused campaigns, he has supported patient access to numerous medical and diagnostic products for conditions including cancer, HIV/AIDS, Alzheimer’s disease and immune-driven diseases.

During the COVID-19 pandemic, Mathew was a senior counselor to companies at the forefront of the global public health response, helping to translate complex scientific and business developments to consumer audiences. From early 2020, he supported the first authorized treatment for COVID-19, developed a crisis response strategy for a major Washington, D.C., hospital system and led U.S. advocacy efforts around a client’s vaccine.

He brings a truly global perspective to his work, drawing on his knowledge of worldwide health care systems. At Ogilvy Healthworld in London, he advised clients on EU and UK policy environments, helping to advance critical conversations on drug pricing and health care system reform. He spent eight months on placement with a Fortune 100 company developing their corporate response to Brexit, advising senior executives on managing the business impact across consumer, medical device and pharmaceutical businesses.

Mathew holds an Msc International Relations from London School of Economics and BA (Hons) History (MA Oxon) from Oxford University. He has appears on BBC News 24 to give analysis on EU and UK politics, presented at the Berlin Foreign Policy Forum and has written commentary for numerous media outlets.